Invitrogen™ Kit ELISA human beta IR

Ref.: BL-RE-090574Manufacturer ref.: KHR9111 96 tests
€814.00 excl. VAT

The human insulin receptor (Hu IRβ) beta-subunit (BELISA) quantifies the IRβ Hu in human cell and tissue lysates. The dosage will recognize only natural and recombinant human IRβ. Cross-reactivity was observed...

Accession number
P06213, P15127, P15208
Dose range
0.94-60 ng/ml
Sensitivity of the dosage
0.5 ng
Concentration
0.94 to 60 ng/ml
Conjugate
HRP
Brand
Invitrogen

The human insulin receptor (Hu IRβ) beta-subunit (BELISA) quantifies the IRβ Hu in human cell and tissue lysates. The dosage will recognize only natural and recombinant human IRβ. Cross-reactivity was observed...

The human insulin receptor (Hu IRβ) beta-subunit (BELISA) quantifies the IRβ Hu in human cell and tissue lysates. The dosage will recognize only natural and recombinant human IRβ. Cross-reactivity was observed in mouse and rat cells. The principle of the human solid-phase L-ELISA sandwich (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of paired antibodies. A target-specific antibody was pre-assembled in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.

The insulin receptor (RI) is a heterodimeric protein complex with an intracellular beta subunit and an extracellular alpha subunit, which is disulfide bound to a transmembrane segment. Insulin ligand binds to the IR and initiates molecular signaling pathways that promote glucose uptake in cells and glycogen synthesis. Insulin binding to IR induces phosphorylation of intracellular tyrosine kinase domains and recruitment of intracellular proteins containing several SH2 and SH3 domains that serve as signaling intermediates for the pleiotropic effects of insulin. Order information

Shipping conditions: Wet ice

Sensitivity

Sensitivity of dosage: 0.5 ng.

Measurement range

Dose range: 0.94-60 ng/ml.

Duration of dosing

Total duration of dosing: 4 hours.

Reproducibility

Coefficient of intra-dose variation 5.4%, inter-dose 8.2%.

Target

Target: Human, mouse and rat.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)10232303
Specifications
Accession numberP06213, P15127, P15208
Dose range0.94-60 ng/ml
Sensitivity of the dosage0.5 ng
Concentration0.94 to 60 ng/ml
ConjugateHRP
Product typeKit ELISA
Type of sampleCellular lysates
Type of substrateTyrosine kinases of receptor
Target speciesHuman, mouse, rat
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)16337, 24954, 3643
Gene symbol(s)CD220,HHF5
Incubation time4 h
Coefficient of inter-dose variation8.2%
Coefficient of intra-dose variation5.4%
Contents of kits96-well pre-coated plate, Standard dilution stamp, Standard dilution stamp, Antibodies detection, Anti-RPH, HRP diluent, Wash pad, Chromogen, Stop solution, Adhesive plate covers
Marker or dyeHRP
Genetic markerInfrared
Quantity96 tests
Regulatory statusRUO
TargetHuman, mouse and rat
Test time1 h 20 min
Physical characteristics
Volume of sampleCell Lysate ,10 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h

Origin and customs

Manufacturer ref.KHR9111
Country of originAutriche
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.